Closantel; a veterinary drug with potential severe morbidity in humans
Tóm tắt
Closantel is a halogenated salicylanilide with a potent anti parasitic activity. It is widely used in management of parasitic infestation in animals, but is contraindicated in humans. A 34-year-old man with depression was referred to our center with progressive loss of vision in both eyes 10 days after unintentional ingestion of three 500 mg tablets of Closantel. On fundus examination, left optic disc margin was blurred. His bilateral visual acuity was no light perception (NLP) despite prescribed IV erythropoietin injections 20,000 units daily for 3 days and 1gr intravenous methylprednisolone acetate for 3 days followed by 1 mg/kg oral prednisolone. On macular optical coherence tomography (OCT), a disruption in outer retina was observed. Electroretinogram and visual evoked potential tests showed visual pathway involvement. Destruction of neurosensory retina and visual pathways after accidental Closantel use is related to severe visual loss. This case alerts us about the destructive effect of this drug on humans even in low dosage which necessitates preventive efforts to reduce the chance of this morbid side effect.
Tài liệu tham khảo
Bergmann I, Frimlova G, Just S, Schaper A, Stürzebecher A, Radamm C, et al. Blindness caused by self-treatment with the veterinary drug closantel. XXXIII International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 28–31 May 2013, Copenhagen, Denma. Clin Toxicol (Phila). 2013;51:285–6.
van der Lugt JJ, Venter I. Myelin vacuolation, optic neuropathy and retinal degeneration after closantel overdosage in sheep and in a goat. J Comp Pathol. 2007;136(2–3):87–95.
Gill PA, Cook RW, Boulton JG, Kelly WR, Vanselow B, Reddacliff LA. Optic neuropathy and retinopathy in closantel toxicosis of sheep and goats. Aust Vet J. 1999;77(4):259–61.
Borges AS, Mendes LC, de Andrade AL, Machado GF, Peiro JR. Optic neuropathy in sheep associated with overdosage of closantel. Vet Hum Toxicol. 1999;41(6):378–80.
t Hoen E, Hodgkin C. Harmful human use of donated veterinary drug. Lancet. 1993;342(8866):308–9.
Essabar L, Meskini T, Ettair S, Erreimi N, Mouane N. Harmful Use of Veterinary Drugs: Blindness Following Closantel Poisoning in a 5-Year-Old Girl. Asia Pac J Med Toxicol. 2014;3:173–5.
Badrane N, Abbada A, Chaoui H, Aoued L, Rhalem N, Benjelloun BS, Bencheikh RS. Blindness following closantel poisoning: Report of three cases. XXXIII International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 28–31 May 2013, Copenhagen, Denmark. Clin Toxicol (Phila). 2013;51:280.
Koziolek MJ, Patschan D, Desel H, Wallbach M, Callizo J. Closantel Poisoning Treated With Plasma Exchange. JAMA Ophthalmology. 2015;133(6):718–20.
Saminathan R, Babuji S, Sethupathy S, Viswanathan P, Balasubramanian T, Gopalakrishanakone P. Clinico-toxinological characterization of the acute effects of the venom of the marine snail, Conus loroisii. Acta Trop. 2006;97(1):75–87.
Kanno T, Kurotaki T, Yamada N, Yamashita K, Wako Y, Tsuchitani M. Activity of 20, 30-Cyclic Nucleotide 30-Phosphodiesterase (CNPase) in Spinal Cord with Spongy Change Inducedby a Single Oral Dose of Aniline in Rats. Toxicol Pathol. 2010;38(3):359–6511.
Morgan KT, Gross EA, Lyght O, Bond JA. Morphologic and biochemical studies of a nitrobenzene-induced encephalopathy in rats. Neurotoxicology. 1985;6(1):105–16.
Barlow AM, Sharpe JAE, Kincaid EA. Blindness in lambs due to inadvertent closantel overdose. Vet Rec. 2002;151:125–6.